Related Experiment Video
Updated: Jan 12, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Reliability, quality, and science popularization of diabetes knowledge information in China video sharing platform: A
Ke-Xin Sun1, Chen Cui1, Fei Mu1
1Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Objective:
More and more diabetes individuals are using internet video platforms for self-management of blood glucose in China. TikTok, WeChat, and Bilibili have gained popularity because of easy access to health information. However, the quality, reliability, and science popularization of health information on these platforms have still not been fully assessed, and studies comparing the three platforms are lacking. A cross-sectional study was established to evaluate the reliability, quality, and science popularization of diabetes health information on Chinese Internet video platforms.
Methods:
This study used "diabetes" as a keyword to identify the top 100 videos meeting the specified criteria on each platform, resulting in 300 videos. The modified DISCERN score, the Journal of the American Medical Association Score (JAMA) benchmark criteria, and Global Quality Scores (GQS) were employed to assess the reliability of videos. This study developed criteria to evaluate the science popularization of the platforms. Each video was assessed based on the health information categories recommended by the Chinese Diabetes Guidelines (2024).
Results:
Of the videos retrieved, 50.67% (152/300) were posted by certified medical professionals. Patient education was the most frequently discussed topic (120/300, 40.00%), including diet and lifestyle interventions. The median DISCERN score for the 300 videos was 3.00 (interquartile range (IQR): 2.00-4.00). The science dissemination score was 67.00 (IQR: 58.00-74.25), and the median GQS was 3. There was no significant difference in JAMA scores among the three platforms (p = 0.095). Bilibili received the highest science popularization score (median: 70.00, IQR: 63.45-77.00) and guideline score (median: 2.00, IQR: 1.00-4.00). Although healthcare professionals have a higher audience focus, video quality is inferior to non-healthcare professionals.
Conclusion:
The results of this cross-sectional study suggest that videos of diabetes information from Internet platforms in China are not satisfactory. Compared with TikTok and WeChat, Bilibili has the highest quality of popular science videos. Health regulatory authorities should improve the enthusiasm of professional medical staff to participate in scientific communication, crack down on false information, and improve the quality of popular science works and public health literacy.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...